Online citations, reference lists, and bibliographies.

Cytoreductive Surgery In Ovarian Cancer: Why, When, And How?

Roberts
Published 1996 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Retrospective evidence supports the value of optimal cytoreductive surgery in the initial therapy of patients with advanced ovarian cancer. Specialized procedures, including radical pelvic surgery, bowel resection, and diaphragm resections, are frequently necessary to accomplish optimal cytoreduction. Cytoreduction and total gross tumor removal are possible more frequently with new surgical instruments such as the Cavitron ultrasonic surgical aspirator and argon beam laser. Pelvic and periaortic lymph node resection is an important aspect of cytoreductive surgery, and systematic removal of grossly uninvolved lymph nodes may improve survival. Secondary cytoreductive surgery appears to benefit a select group of patients.
This paper references
10.1097/00006254-199602000-00012
The Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.The Effect of Debulking Surgery After Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer
M. V. D. Burg (1996)
Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.
C. Griffiths (1975)
10.1016/0090-8258(91)90316-W
The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma.
J. Soper (1991)
10.1016/0090-8258(88)90262-4
Evaluation of treatment and survival after positive second-look laparotomy☆
K. Podratz (1988)
10.1002/1097-0142(19880615)61:12<2571::AID-CNCR2820611231>3.0.CO;2-O
Second‐look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration
S. Lippman (1988)
10.1016/S0002-9378(94)70090-7
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
W. Hoskins (1994)
10.1016/0090-8258(84)90040-4
Stage III epithelial ovarian cancer: the role of maximal surgical reduction.
G. Delgado (1984)
10.1016/0090-8258(91)90336-4
Reverse hysterocolposigmoidectomy (RHCS) for resection of panpelvic tumors.
W. Barnes (1991)
Survival of Patients Following Secondary Cytoreductive Surgery in Ovarian Cancer
J. Berek (1983)
Prognostic parameters in patients with advanced ovarian malignant tumors.
R. Pohl (1984)
10.1016/0090-8258(82)90012-9
Lower urinary tract resection as part of cytoreductive surgery for ovarian cancer.
J. Berek (1982)
10.1097/00006254-198706000-00021
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.
P. Conte (1986)
10.1016/S0140-6736(88)90640-X
FAILURE OF SECOND-LOOK LAPAROTOMY TO INFLUENCE SURVIVAL IN EPITHELIAL OVARIAN CANCER
D. Luesley (1988)
Modified posterior exenteration for ovarian cancer.
S. Eisenkop (1991)
Primary Cytoreductive Surgery for Epithelial Ovarian Cancer
N. Hacker (1983)
Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspirator.
M. Adelson (1988)
10.1016/0090-8258(89)90175-3
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.
W. Hoskins (1989)
10.1006/gyno.1994.1257
The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery.
R. Farias-Eisner (1994)
10.1016/0090-8258(89)90074-7
Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer
F. J. Montz (1990)
10.1111/j.1471-0528.1968.tb02901.x
A RADICAL OPERATION FOR FIXED OVARIAN TUMOURS
C. Hudson (1968)
10.1016/0020-7292(87)90259-1
Pelvic lymphadenectomy in operative treatment of ovarian cancer.
E. Burghardt (1986)
10.1016/0090-8258(92)90100-W
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.
W. Hoskins (1992)
Cisplatin based combination chemotherapy for advanced ovarian
SE Vogl
10.1006/gyno.1994.1346
Epithelial ovarian carcinoma: principles of primary surgery.
W. Hoskins (1994)
10.1200/jco.1988.6.6.983
The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.
M. Piver (1988)
10.1016/0002-9378(92)91345-B
The cavitational ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancer
P. Rose (1992)
10.1200/JCO.1986.4.4.515
Prognostic factors in advanced ovarian carcinoma.
J. Redman (1986)
10.1016/0090-8258(90)90415-H
Electrosurgical debulking of ovarian cancer: a new technique using the argon beam coagulator.
E. Brand (1990)
10.1006/gyno.1993.1277
Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival.
S. Eisenkop (1993)
10.1016/0020-7292(91)90517-9
Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer.
E. Burghardt (1991)
10.1002/1097-0142(19830601)51:11<2024::AID-CNCR2820511111>3.0.CO;2-I
Cis‐platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens
S. Vogl (1983)
10.1006/gyno.1995.1123
Loop electrosurgical excision procedure for intensified cytoreduction of ovarian cancer.
J. Fanning (1995)
Evaluation of cytoreductive surgery with lymphadenectomy including para-aortic nodes for advanced ovarian cancer.
J. Kigawa (1993)
10.1016/0090-8258(88)90298-3
Debulking surgery for ovarian cancer with the Cavitron Ultrasonic Surgical Aspirator (CUSA)--a preliminary report.
M. Deppe (1988)
10.1002/1097-0142(19921015)70:8<2129::AID-CNCR2820700820>3.0.CO;2-U
Radical surgical procedure improves survival time in patients with recurrent ovarian cancer
F. Jänicke (1992)
10.1016/0090-8258(92)90107-T
The impact of subspecialty training on the management of advanced ovarian cancer.
S. Eisenkop (1992)
10.1111/j.1471-0528.1985.tb01359.x
The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery
E. Wiltshaw (1985)
10.1016/0020-7292(90)90156-f
Splenectomy during primary maximal cytoreductive surgery for epithelial ovarian cancer.
E. W. Sonnendecker (1989)
10.1016/0020-7292(91)90338-6
Carbon dioxide laser vaporization of diaphragmatic metastases for cytoreduction of ovarian epithelial cancer.
B. Patsner (1990)
Secondary cytoreductive surgery in ovarian cancer.
G. Michel (1989)
10.1016/S0140-6736(84)90594-4
RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA
J. Neijt (1984)
10.1006/gyno.1995.1061
Cytoreductive Surgery in Advanced Epithelial Cancer of the Ovary: The Impact of Aortic and Pelvic Lymphadenectomy
N. Spirtos (1995)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar